Exploring 4-HO-DALT. To explore a different substance…

Names:
4-HO-DALT
N,N-Diallyl-4-hydroxytryptamine
IUPAC name:
3-{2-[Di(prop-2-en-1-yl)amino]ethyl}-1H-indol-4-ol
5530 · C16H20N2O · 256.343
InChI=1S/C16H20N2O/c1-3-9-18(10-4-2)11-8-13-12-17-14-6-5-7-15(19)16(13)14/h3-7,12,17,19H,1-2,8-11H2
JVIWQWJXRKVJTA-UHFFFAOYSA-N This stereoisomer Any stereoisomer
C=CCN(CCc1c[nH]c2c1c(O)ccc2)CC=C

Brandt, SD; Kavanagh, PV; Dowling, G; Talbot, B; Westphal, F; Meyer, MR; Maurer, HH; Halberstadt, AL. Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives. Drug Test. Analysis, 1 Jan 2017, 9 (1), 115-126. 1.3 MB. https://doi.org/10.1002/dta.1974 Open access DOI

Klein, LM; Cozzi, NV; Daley, PF; Brandt, SD; Halberstadt, AL. Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs. Neuropharmacology, 1 Feb 2018, n/a. 882 kB. https://doi.org/10.1016/j.neuropharm.2018.02.028

Chanoclavine
12-MeO-6-Me-Ergoline
O-2475
5901
5820
5-MeO-2-Me-MTHPI
Fumigaclavine B
(Bicyclo) 5-MeO-T
17 October 2018 · Creative Commons BY-NC-SA ·